|
Delayed
London S.E.
17:55:43 08/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 200.10 GBX | +0.05% |
|
+4.49% | +56.33% |
| 09-24 | Diaceutics PLC And Syndax Pharmaceuticals, Inc. Expand Multi-Year Relay Partnership | CI |
| 09-22 | EARNINGS: Origin Enterprises beats operating profit target | AN |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 224M | - | - | - | - | |||||
| 683B | AAA | ||||||||
| 78.78B | BBB | ||||||||
| 65B | AA | - | |||||||
| 64.57B | AA | ||||||||
| 47.01B | AAA | ||||||||
| 45.99B | B | ||||||||
| 30.64B | AAA | ||||||||
| 26.42B | BB | ||||||||
| 24.09B | A | ||||||||
| 22.25B | AAA | ||||||||
| 21.46B | BBB | ||||||||
| 15.96B | AAA | ||||||||
| 15.86B | AAA | ||||||||
| 14.36B | AAA | ||||||||
| 14.85B | BBB | ||||||||
| 13.55B | A | ||||||||
| 12.89B | AA | ||||||||
| 12.1B | A | ||||||||
| 11.96B | AA | ||||||||
| Average | 61.05B | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
















